このエントリーをはてなブックマークに追加


ID 69045
FullText URL
fulltext.pdf 1010 KB
Author
Uka, Mayu Department of Radiology, Okayama University Hospital
Iguchi, Toshihiro Department of Radiology, Okayama University Hospital Kaken ID
Bekku, Kensuke Department of Urology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Yamanoi, Tomoaki Department of Urology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences
Mitsuhashi, Toshiharu Center for Innovative Clinical Medicine, Okayama University Hospital Kaken ID researchmap
Gobara, Hideo Division of Medical Informatics, Okayama University Hospital ORCID Kaken ID publons researchmap
Umakoshi, Noriyuki Department of Radiology, Okayama University Hospital
Kawabata, Takahiro Department of Radiology, Okayama University Hospital
Tomita, Koji Department of Radiology, Okayama University Hospital
Matsui, Yusuke Department of Radiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University
Araki, Motoo Department of Urology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences ORCID Kaken ID publons researchmap
Hiraki, Takao Department of Radiology, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University Kaken ID publons researchmap
Abstract
Background: No direct cost comparison has been conducted between percutaneous cryoablation (PCA) and robot-assisted partial nephrectomy (RAPN) for clinical T1a renal cell carcinoma (RCC) in Japan. This study aimed to compare their costs.
Methods: We retrospectively analyzed data from 212 PCAs (including 155 with transcatheter arterial embolization) and 119 RAPN cases performed between December 2017 and May 2022.
Results: PCA patients were older with higher American Society of Anesthesiologists scores, Charlson Comorbidity Index, and history of previous RCC treatment, cardiovascular disease, and antithrombotic drug use than RAPN patients. PCA was associated with a significantly shorter procedure time and hospitalization duration with fewer major complications than those associated with RAPN. While PCA incurred a slightly lower total cost (1,123,000 vs. 1,155,000 yen), it had a significantly higher procedural cost (739,000 vs. 693,000 yen) and markedly worse total (− 93,000 vs. 249,000 yen) and procedural income-expenditure balance (− 189,000 vs. 231,000 yen) than those of RAPN. After statistical adjustment, PCA demonstrated significantly higher total (difference: 114,000 yen) and procedural costs (difference: 72,000 yen), alongside significantly worse total (difference: − 358,000 yen) and procedural income-expenditure balances (difference: − 439,000 yen). The incremental cost-effectiveness ratio was more favorable for PCA than for RAPN.
Conclusion: For high- risk patients, PCA demonstrated a safer option with shorter hospitalization duration than those of RAPN. Although PCA was more cost-effective, its higher procedural cost and unfavorable income-expenditure balance require careful evaluation, especially for large tumors that require three or more needles.
Keywords
Renal cancer
Cryoablation
Robot-assisted partial nephrectomy
Cost
Cost effectiveness
Note
The version of record of this article, first published in International Journal of Clinical Oncology, is available online at Publisher’s website: http://dx.doi.org/10.1007/s10147-025-02783-5
Published Date
2025-06-06
Publication Title
International Journal of Clinical Oncology
Volume
volume30
Issue
issue8
Publisher
Springer Science and Business Media LLC
Start Page
1621
End Page
1630
ISSN
1341-9625
NCID
AA11086579
Content Type
Journal Article
language
English
OAI-PMH Set
岡山大学
Copyright Holders
© The Author(s) 2025
File Version
publisher
PubMed ID
DOI
Web of Science KeyUT
Related Url
isVersionOf https://doi.org/10.1007/s10147-025-02783-5
License
http://creativecommons.org/licenses/by/4.0/
Citation
Uka, M., Iguchi, T., Bekku, K. et al. Percutaneous cryoablation versus robot-assisted partial nephrectomy for small renal cell carcinoma: a retrospective cost analysis at Japanese single-institution. Int J Clin Oncol 30, 1621–1630 (2025). https://doi.org/10.1007/s10147-025-02783-5
助成情報
( 国立大学法人岡山大学 / Okayama University )